These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15749275)

  • 1. Beyond PEGylation.
    Whelan J
    Drug Discov Today; 2005 Mar; 10(5):301. PubMed ID: 15749275
    [No Abstract]   [Full Text] [Related]  

  • 2. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
    Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
    J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging PEGylated drugs.
    Kang JS; Deluca PP; Lee KC
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of particulate reservoir-containing, capsulelike, and self-folding polymer microstructures for drug delivery.
    Guan J; He H; Lee LJ; Hansford DJ
    Small; 2007 Mar; 3(3):412-8. PubMed ID: 17285662
    [No Abstract]   [Full Text] [Related]  

  • 6. Lectin functionalized complexation hydrogels for oral protein delivery.
    Wood KM; Stone G; Peppas NA
    J Control Release; 2006 Nov; 116(2):e66-8. PubMed ID: 17718976
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether.
    Bhadra D; Bhadra S; Jain NK
    J Pharm Pharm Sci; 2005 Sep; 8(3):467-82. PubMed ID: 16401394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy.
    Zhao H; Peng P; Longley C; Zhang Y; Borowski V; Mehlig M; Reddy P; Xia J; Borchard G; Lipman J; Benimetskaya L; Stein CA
    J Control Release; 2007 Jun; 119(2):143-52. PubMed ID: 17397960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-phospholipid micelles for the delivery of amphotericin B.
    Vakil R; Kwon GS
    J Control Release; 2005 Jan; 101(1-3):386-9. PubMed ID: 15822230
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled drug delivery through tailor-made blend polymeric membranes.
    Stamatialis DF; Rolevink HH; Balster J; Koops GH
    J Control Release; 2005 Jan; 101(1-3):302-4. PubMed ID: 15678611
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of gene delivery systems for the epsilon-poly-L-lysine producer, Streptomyces albulus.
    Hamano Y; Nicchu I; Hoshino Y; Kawai T; Nakamori S; Takagi H
    J Biosci Bioeng; 2005 Jun; 99(6):636-41. PubMed ID: 16233843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTMC and MPEG-PTMC microparticles for hydrophilic drug delivery.
    Zhang Z; Foks MA; Grijpma DW; Feijen J
    J Control Release; 2005 Jan; 101(1-3):392-4. PubMed ID: 15822232
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.
    Hayes ME; Drummond DC; Hong K; Zheng WW; Khorosheva VA; Cohen JA; C O N; Park JW; Marks JD; Benz CC; Kirpotin DB
    Mol Pharm; 2006; 3(6):726-36. PubMed ID: 17140260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methacrylamide-oligolactates as building blocks for targeted biodegradable polymeric micelles to deliver photosensitizers.
    Rijcken CJ; Leemhuis M; Hofman JW; van Zeeland F; Ramzi A; van Nostrum CF; Hennink WE
    J Control Release; 2006 Nov; 116(2):e10-2. PubMed ID: 17718937
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers.
    Wang N; Dong A; Tang H; Van Kirk EA; Johnson PA; Murdoch WJ; Radosz M; Shen Y
    Macromol Biosci; 2007 Nov; 7(11):1187-98. PubMed ID: 17665412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection.
    Zillies JC; Zwiorek K; Winter G; Coester C
    Anal Chem; 2007 Jun; 79(12):4574-80. PubMed ID: 17506521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.
    Chiappetta DA; Sosnik A
    Eur J Pharm Biopharm; 2007 Jun; 66(3):303-17. PubMed ID: 17481869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization.
    Craparo EF; Pitarresi G; Bondì ML; Casaletto MP; Licciardi M; Giammona G
    Macromol Biosci; 2008 Mar; 8(3):247-59. PubMed ID: 18041108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells.
    Peeters L; Sanders NN; Jones A; Demeester J; De Smedt SC
    J Control Release; 2007 Aug; 121(3):208-17. PubMed ID: 17630013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three significant highlights of controlled drug delivery over the past 55 years: PEGylation, ADCs, and EPR.
    Hoffman AS; Lai JJ
    Adv Drug Deliv Rev; 2020; 158():2-3. PubMed ID: 32512028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.